OzgurSahinLab

Works on Translational Cancer Biology
@muschollings
(account managed by lab members)

[MUSC Research @ResearchMUSC]

The MUSC Emerging Scholars Travel Award supports conference travel for students, research fellows & postdocs, like Kubra Calisir Unsal, pictured at the @AACR Special Conference in Cancer Research in Boston, MA.

[OzgurSahinLab @OzgurSahinLab]

Two posters from Sahin Lab in AACR 2025 in Chicago!

Ozge and Kubra presented their research in poster session of AACR.

[OzgurSahinLab @OzgurSahinLab]

If you are interested in cancer immunology or bioinformatics, see our lab page for two open Postdoctoral Fellow positions.
We also have an open position for a Research Specialist.

https://t.co/NTfqul0INI

[Cell Chemical Biology @CellChemBiol]

Ozgur Sahin and colleagues @OzgurSahinLab @MUSC_COM @MedUnivSC developed a highly potent inhibitor of lysyl oxidase for TNBC. The inhibitor reduces tumor stiffness and improves drug penetration. https://t.co/iRHalNO0HV

[OzgurSahinLab @OzgurSahinLab]

See the new Research Specialist position in our lab!

UNIV - Research Specialist I - Department of Biochemistry and Molecular Biology - Charleston, South Carolina, United States (https://t.co/EHQh659fpt)

[OzgurSahinLab @OzgurSahinLab]

See the new Postdoctoral Fellow position in our lab!

UNIV-Postdoctoral Fellow-Department of Biochemistry - Charleston, South Carolina, United States (https://t.co/EHQh659fpt)

[OzgurSahinLab @OzgurSahinLab]

See the great news from our lab !

"Hollings team marks milestone in progress toward investigational new drug for triple-negative breast cancer"
https://t.co/pvqmjywjzj

[Özgür Şahin @ozgursahin1905]

Happy to see that our paper on new lysyl oxidase inhibitors in overcoming chemoresistance in TNBC is out today! I thank my lab and our collaborators both at MUSC and USC.

[OzgurSahinLab @OzgurSahinLab]

There is so much to celebrate 🎉🎉
1. Kubra passed the candidacy exam.
2. Accepted two research papers.
3. Welcome to our new members: HM and Sezen.

[OzgurSahinLab @OzgurSahinLab]

An opening for a highly motivated and collegial Postdoctoral Fellow in our lab!
.
.
Please see the details below.

https://t.co/lCYGSyNKav

[OzgurSahinLab @OzgurSahinLab]

Presenting three posters at AACR Annual Meeting 2024!

Ozge presented her latest publication: Targeting PDE4D reinstates toxic PARP trapping via cAMP-ROS-DNA damage axis and restores the efficacy of standard of care in treatment-refractory ER+ breast cancer.

[OzgurSahinLab @OzgurSahinLab]

Congratulations to Dr. Sahin, the Winter 2024 College of Medicine Research Excellence Award recipient.

https://t.co/8PuapKjzib

[OzgurSahinLab @OzgurSahinLab]

See the news related to our latest publication!

https://t.co/4pQsu8uxHY

[OzgurSahinLab @OzgurSahinLab]

Our new paper on overcoming resistance to the iconic antibody-drug conjugate, T-DM1 in HER2+ breast cancer has been published in Cancer Research!

https://t.co/3xAWX5K0ch

[OzgurSahinLab @OzgurSahinLab]

Now Dr. Ozge Saatci!
We are thrilled to share the news that Ozge has successfully defended her Ph.D. thesis. Her PhD is distinguished by a noteworthy contribution of high-impact papers. We have every confidence that she will continue to achieve even more in her future endeavors!

[OzgurSahinLab @OzgurSahinLab]

From MUSC - USC Drug Discovery and Development Retreat.
We had the opportunity to engage with numerous presentations on translational cancer research, including Dr. Sahin’s talk. Ozge, Metin, and Emre presented their poster and Ozge received the Best Poster Presentation Award!

[OzgurSahinLab @OzgurSahinLab]

Exciting news from our laboratory!

Our postdoctoral researcher, Metin, has been awarded the prestigious Hollings Postdoctoral Fellowship —a well-deserved recognition of his outstanding work.

[OzgurSahinLab @OzgurSahinLab]

On November 4th, we embarked on a remarkable journey, cycling 10 miles to raise awareness for cancer in LOWVELO. The ride exemplified the profound impact that collective action can have in spreading awareness and advancing cancer research and support.

https://t.co/0KGOTiz7zs

[Özgür Şahin @ozgursahin1905]

Our new paper is out @NatureComms. Many thanks to @OzgurSahinLab at @muschollings and excellent collaborators. Special thanks to @AmericanCancer for funding this work. We are now working on translating our findings to the clinics in the very near future.

https://t.co/meFvOZbDHZ

[OzgurSahinLab @OzgurSahinLab]

Donate now for innovative and lifesaving cancer research! #LOWVELO

https://t.co/0KGOTiz7zs